文献速递膀胱癌与上尿路尿路上皮癌

卡介苗不可及时如何治疗多灶性Ta高级别病变

How to Treat Multifocal Ta High-grade Disease if Bacillus Calmette-Guérin Is Unavailable.
PubMed 文献 · Eur Urol Oncol · 2019-07-16

一例71岁男性多灶性复发性高级别pTa膀胱癌患者,在卡介苗(BCG)不可及的情况下,讨论了根治性膀胱切除术与保守膀胱内治疗(吉西他滨/多西他赛或表柔比星/干扰素联合治疗、器械辅助膀胱内治疗、免疫治疗试验)的利弊。

要点

  • 立即根治性膀胱切除术生存极佳,但约50%患者可能过度治疗。
  • 保守方案可考虑膀胱内联合治疗如吉西他滨/多西他赛或表柔比星/干扰素。
  • 器械辅助膀胱内治疗正成为可考虑的选择,患者也可参加免疫治疗等试验。

核心结论

  • 在BCG不可及时,多灶性Ta高级别病变的治疗选择包括立即根治性膀胱切除术、保守的膀胱内联合治疗、器械辅助膀胱内治疗或参加临床试验。

研究设计与样本

  • 本文为一例71岁男性多灶性复发性高级别pTa膀胱癌病例讨论,患者初始表现为多灶性大pTa低级别肿瘤伴原位癌,经尿道切除术后接受6个月丝裂霉素C治疗,26个月后转移至本机构。

主要发现

  • 立即根治性膀胱切除术生存极佳,但约50%患者可能过度治疗。
  • 保守方法可考虑膀胱内联合治疗如吉西他滨/多西他赛或表柔比星/干扰素。
  • 器械辅助膀胱内治疗正成为可考虑的选择,患者也可参加免疫治疗等试验。

临床怎么用

  • 原文未据此给出推荐,仅讨论各治疗方案的利弊。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 71-yr-old man was transferred to our institution with multiple and recurrent high-grade pTa bladder cancer 26mo after an initial presentation of multiple and large pTa low-grade tumors and concomitant carcinoma in situ, treated with transurethral resection plus 6-mo postoperative mitomycin C. This case discusses several treatment options in the absence of bacillus Calmette-Guérin (BCG). Immediate radical cystectomy is an option with excellent survival, since there is a substantial risk of understaging and disease progression; however, this results in overtreatment in ∼50% of these patients. Therefore, a conservative approach could be intravesical combination therapy such as gemcitabine/docetaxel or epirubicin/interferon. In addition, device-assisted intravesical therapy is becoming an option to consider. Finally, patients could be included in trials such as immunotherapy trials. PATIENT SUMMARY: This 71-yr-old patient was diagnosed with recurrent, moderately severe noninvasive bladder tumors, which were removed. The recommended additional therapy, intravesical bacillus Calmette-Guérin (BCG) instillations, was not available. Both the pros and the cons of radical surgery (bladder removal) and a more conservative approach (other intravesical treatments) are discussed.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Witjes JA, Brausi M, Malmstrom PU, et al. How to Treat Multifocal Ta High-grade Disease if Bacillus Calmette-Guérin Is Unavailable. Eur Urol Oncol. 2019. PMID: 31324506. doi:10.1016/j.euo.2019.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。